Inspiratory Muscle Training and Asthma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a pilot study which will assess the feasibility of a follow on main study. This study will examine the impact of inspiratory muscle training on quality of life, rescue drug medication usage, and other markers of asthma in adult asthmatics in the UK.
| Condition | Intervention |
|---|---|
|
Asthma |
Other: inspiratory muscle training |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
| Official Title: | Inspiratory Muscle Training as a Novel Approach in the Treatment of Asthma |
- Assess the feasibility of the methods adopted [ Time Frame: This will depend on when ethical approval is received. Participants will be actively engaged for 11 or 12 weeks ] [ Designated as safety issue: No ]
Two weeks at the start of the study (post informed consent) will be required for diary completion (asthma control diary; Asthma Quality of Life Questionnaire with Standardised Activities).
One week for pre-intervention testing (body plethysmography, exhaled nitric oxide, blood immunoglobulin G, respiratory muscle strength).
Six weeks of inspiratory muscle training (details provided elsewhere).
One week for post-intervention testing (plethysmography, exhaled nitric oxide, blood immunoglobulin G, respiratory muscle strength).
Two weeks will be required towards the end of inspiratory muscle training for diary completion (asthma control diary; Asthma Quality of Life Questionnaire with Standardised Activities). This two week period will coincide with the final week of inspiratory muscle training and the first week following it.
| Estimated Enrollment: | 20 |
| Study Start Date: | January 2013 |
| Estimated Study Completion Date: | May 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Experimental
6 weeks of inspiratory muscle training, 6 days per week. The intensity of training will be equivalent to 50% of pre-training maximal inspiratory mouth pressure and will be adapted weekly to reflect the improvement in inspiratory muscle strength
|
Other: inspiratory muscle training
Both groups will undertake six weeks of inspiratory muscle training (POWERbreathe, H&B International Ltd, UK), six days per week, with the only difference being the load set on the inspiratory muscle training device. For the real inspiratory muscle training group this load will be set to around 50% of maximal inspiratory mouth pressure and for the sham inspiratory muscle training group this load will be set to around 5% of maximal inspiratory mouth pressure.
|
|
Sham Comparator: Sham Comparator
6 weeks of sham inspiratory muscle training, 6 days per week. The intensity of training will be equivalent to 5% of pre-training inspiratory mouth pressure throughout the 6 week period.
|
Other: inspiratory muscle training
Both groups will undertake six weeks of inspiratory muscle training (POWERbreathe, H&B International Ltd, UK), six days per week, with the only difference being the load set on the inspiratory muscle training device. For the real inspiratory muscle training group this load will be set to around 50% of maximal inspiratory mouth pressure and for the sham inspiratory muscle training group this load will be set to around 5% of maximal inspiratory mouth pressure.
|
Eligibility| Ages Eligible for Study: | 18 Years to 59 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosed as having partly controlled or uncontrolled asthma according to the Global Initiative for Asthma guidelines
- Aged 18 to 59 years.
Exclusion Criteria:
- Current smoker.
- Well controlled asthma.
- Undertaken a structured program of inspiratory muscle training within the past three months.
- Participating in another study that is not solely observational.
Contacts and Locations| United Kingdom | |
| Respiratory Centre, Queen Alexandra Hospital, Cosham | Not yet recruiting |
| Portsmouth, Hampshire, United Kingdom, PO6 3LY | |
| Contact: Dominic Reynish +440232286000 dominic.reynish@porthosp.nhs.uk | |
| Contact: Sumita Kerley +440232286000 sumita.kerley2@porthosp.nhs.uk | |
| Principal Investigator: Dominic Reynish | |
| University of Portsmouth | Not yet recruiting |
| Portsmouth, Hampshire, United Kingdom, PO6 3LY | |
| Contact: Mitch Lomax +4402392845297 mitch.lomax@port.ac.uk | |
| Contact: Janis Shute +4402392842152 jan.shute@port.ac.uk | |
More Information
No publications provided
| Responsible Party: | Mitch Lomax, Senior Lecturer, University of Portsmouth |
| ClinicalTrials.gov Identifier: | NCT01727765 History of Changes |
| Other Study ID Numbers: | IMT and Asthma |
| Study First Received: | November 7, 2012 |
| Last Updated: | November 12, 2012 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by University of Portsmouth:
|
Asthma, inspiratory muscle training |
Additional relevant MeSH terms:
|
Respiratory Aspiration Asthma Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms Bronchial Diseases |
Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013